טוען...
Inhibition of 14-3-3/Tau by Hybrid Small-Molecule Peptides Operating via Two Different Binding Modes
[Image: see text] Current molecular hypotheses have not yet delivered marketable treatments for Alzheimer’s disease (AD), arguably due to a lack of understanding of AD biology and an overreliance on conventional drug modalities. Protein–protein interactions (PPIs) are emerging drug targets, which sh...
שמור ב:
| הוצא לאור ב: | ACS Chem Neurosci |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Chemical
Society
2018
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6256345/ https://ncbi.nlm.nih.gov/pubmed/29722962 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.8b00118 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|